Research assumes that with the expected launch of the potential promising therapies, the market is anticipated to expand in both psoriasis and atopic dermatitis segments. The Unites States accounts for the higher share of the market as compared to the Europe and Japan. The highest market size is due to the increased adoption of high priced biologics. Despite the launch and availability of multiple biologics, only 10% of the patients have access to these treatments and the market continues to remain underpenetrated.

Currently, the Dermatology Drugs market is highly fragmented but offer several commercial opportunities. There remains significant unmet need for safer and cost-effective treatment options. Psoriasis market was nearly USD 6 billion markets in 2016 due to the existing effective TNF alpha treatments. In Acne, retinoids and antibiotics are the mainstay treatments but what makes this indication lucrative is the promising candidates in the pipeline including Foamix’s FMX-101 and Dermiras DRM-101.

Get a free Sample Copy of Global Dermatology Drugs Market @ https://martresearch.com/contact/request-sample/2/38168

Research has provided the forecasts of the Global Dermatology Drugs Market from 2016-2022.

The major segments which have been investigated in the global market from 2016-2022 are:

Market Analysis by Dermatology Key Indications

Market Analysis by Treatment Class/Marketed Drugs

Market Analysis by Regions

The Marketed Therapies undertaken in forecast from 2016-2022 are:

etanercept; Enbrel

infliximab; Remicade

adalimumab; Humira

ustekinumab; Stelara

secukinumab; Cosentyx

ixekizumab; Taltz

golimumab; Simponi

brodalumab; Siliq

guselkamab; Tremfya

Topical Drugs

Oral Antibiotics

The Major Indications in Dermatology Therapy area:

Atopic Dermatitis

Psoriasis

Acne

Rosacea

Leading Companies investigated in the Report are:

Allergan Plc

Valeant Pharmaceuticals

Dermira Inc

Aclaris Therapeutics, Inc

AnaptysBio, Inc

Revance Therapeutics

Foamix Pharmaceuticals

Novan, Inc

Sienna Biopharmaceuticals

Pfizer

Sanofi

Galderma

Leo Pharma

Roviant Sciences

Otsuka Pharmaceuticals

Buy Dermatology Drugs Market Research Report Now @ https://martresearch.com/paymentform/2/38168/Single_User

Table of Contents

Global Dermatology Drugs Market Size, Status and Forecast 2026

Chapter 1 Dermatology Overview

Chapter 2 Key Indications in Dermatology Drugs Market Therapy Area

2.1.     Atopic Dermatitis Overview

2.2.     Psoriasis Overview

2.3.     Acne Overview

2.4.     Rosacea Overview

Chapter 3 Diagnosis Patterns

Chapter 4 Dermatology- Fragmented Market with Several Opportunities

Chapter 5 Epidemiology-Prevalent Population & Segmentations

5.1.     Atopic Dermatitis-Prevalent Population (2016-2022)

5.2.     Psoriasis-Prevalent Population (2016-2022)

5.3.     Acne-Prevalent Population (2016-2022)

5.4.     Rosacea-Prevalent Population (2016-2022)

Chapter 6 Treatment Patterns and Treatment Algorithms in Dermatology Therapeutic Area

6.1.     Atopic Dermatitis-Treatment Practices

6.2.     Psoriasis-Treatment Practices

6.3.     Acne-Prevalent Treatment Practices

6.4.     Rosacea-Treatment Practices

Chapter 7 Market Forecast by Therapeutic Area (2016-2022)

7.1.     Atopic Dermatitis- Market Forecast (2016-2022)

7.2.     Psoriasis- Market Forecast (2016-2022)

7.3.     Acne- Market Forecast (2016-2022)

7.4.     Rosacea- Market Forecast (2016-2022)

Chapter 8 Marketed Drugs and Sales Forecast (2016-2022)

8.1.     Atopic Dermatitis Key Drugs Market Forecast

8.1.1. dupilumab (Dupixent)-Sanofi-Sales forecast 2016-2022

8.1.2. Nemolizumab-Galderma-Sales forecast 2016-2022

8.1.3. Tralokinumab- LEO Pharma-Sales forecast 2016-2022

8.1.4. Crisaborole (Eucrisa)-Pfizer-Sales forecast 2016-2022

8.1.5. RVT-501-Roviant Sciences-Sales forecast 2016-2022

8.1.6. OPA-15406- Otsuka Pharmaceuticals-Sales forecast 2016-2022

8.2.     Psoriasis Key Drugs Market Forecast

8.2.1. etanercept; Enbrel-Sales forecast 2016-2022

8.2.2. infliximab; Remicade-Sales forecast 2016-2022

8.2.3. adalimumab; Humira-Sales forecast 2016-2022

8.2.4. ustekinumab; Stelara-Sales forecast 2016-2022

8.2.5. secukinumab; Cosentyx-Sales forecast 2016-2022

8.2.6. ixekizumab; Taltz-Sales forecast 2016-2022

8.2.7. golimumab; Simponi-Sales forecast 2016-2022

8.2.8. brodalumab; Siliq-Sales forecast 2016-2022

8.2.9. guselkamab; Tremfya-Sales forecast 2016-2022

8.3.     Acne Key Drugs Market Forecast

8.3.1. Acne Topical Drugs Market Sales & Share 2016-2022

8.3.2. Acne Oral Drugs Market Sales & Share 2016-2022

8.4.     Rosacea Key Drugs Market Forecast

8.4.1. Acne Topical Drugs Market Sales & Share 2016-2022

8.4.2. Acne Oral Antibiotics Market Sales & Share 2016-2022

Chapter 9 Market Forecast by Regions (2016-2022)

9.1.     North America- Market Forecast (2016-2022)

9.2.     Europe- Market Forecast (2016-2022)

9.3.     APAC-Market Forecast (2016-2022)

9.4.     ROW- Market Forecast (2016-2022)

Chapter 10 Factors Driving the Market of Dermatology Drugs

Chapter 11 Factors Restraining the Market of Dermatology Drugs

Chapter 12 About Mart Research

Chapter 13 Disclaimer

Chapter 14 Sales Support

Get Inquiry before buy this Report @ https://martresearch.com/contact/enquiry/2/38168

About us: Research is and will always be the key to success and growth for any industry. Most organizations invest a major chunk of their resources viz. time, money and manpower in research to achieve new breakthroughs in their businesses. The outcome might not always be as expected thereby arising the need for precise, factual and high-quality data backing your research. This is where MART RESEARCH steps in and caters its expertise in the domain of market research reports to industries across varied sectors.

Email Us: morris@martresearch.com